Alzheimer's disease is a really devastating disease of the brain with no present cure or therapy to slow down the progression of the disease. Although there is no cure at the moment, the diagnostics of the disease have significantly improved and scientists. For example, the combination of fluorescent dyes (Pittsburgh B compound) with magnetic resonance imaging (MRI) is a key diagnostic tool for predicting the outcome of the disease about 10 years before a patient develops symptoms. Now the first time have discovered that measuring two fatty acids or lipids in the bloodstream is correlated with a higher chance of cognitive decline. This simple blood test is faster, and probably more reliable than an MRI. One of these lipids is ceramide and the higher the lipid is found in the blood the higher the probability of developing dementia. However, this type of diagnosis can help the patient by providing intensive therapy for those patients are highest risk but can also open the door for a lot of controversy as many small and large employers and even insurance companies may not be willing to hire people at risk of developing Alzheimer's disease or may drop their medical coverage all together years before developing the disease.
Read the complete article that was posted today on Medical News:
http://www.medicalnewstoday.com/articles/235462.php
Read the complete article that was posted today on Medical News:
http://www.medicalnewstoday.com/articles/235462.php
No comments:
Post a Comment